PL2346823T3 - Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu - Google Patents

Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu

Info

Publication number
PL2346823T3
PL2346823T3 PL09792268T PL09792268T PL2346823T3 PL 2346823 T3 PL2346823 T3 PL 2346823T3 PL 09792268 T PL09792268 T PL 09792268T PL 09792268 T PL09792268 T PL 09792268T PL 2346823 T3 PL2346823 T3 PL 2346823T3
Authority
PL
Poland
Prior art keywords
phenyl
decan
diaza
spiro
intermediates
Prior art date
Application number
PL09792268T
Other languages
English (en)
Inventor
George G Wu
Gerald Werne
Xiaoyong Fu
Robert K Orr
Frank Xing Chen
Jian Cui
Victoria M Sprague
Fucheng Zhang
Ji Xie
Liansheng Zeng
Louis Peter Castellanos
Yuyin Chen
Marc Poirier
Ingrid Mergelsberg
Original Assignee
Opko Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opko Health Inc filed Critical Opko Health Inc
Publication of PL2346823T3 publication Critical patent/PL2346823T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/46—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
PL09792268T 2008-09-05 2009-09-04 Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu PL2346823T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9447408P 2008-09-05 2008-09-05
EP09792268.6A EP2346823B1 (en) 2008-09-05 2009-09-04 Intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
PCT/US2009/056020 WO2010028232A1 (en) 2008-09-05 2009-09-04 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

Publications (1)

Publication Number Publication Date
PL2346823T3 true PL2346823T3 (pl) 2016-01-29

Family

ID=41402490

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09792268T PL2346823T3 (pl) 2008-09-05 2009-09-04 Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu

Country Status (14)

Country Link
US (2) US9249144B2 (pl)
EP (2) EP2346823B1 (pl)
JP (2) JP5736313B2 (pl)
KR (1) KR101719004B1 (pl)
CN (2) CN102203062B (pl)
AU (1) AU2009289598B2 (pl)
CA (1) CA2736195C (pl)
ES (1) ES2552322T3 (pl)
HK (1) HK1158623A1 (pl)
HU (1) HUE026148T2 (pl)
MX (1) MX2011002475A (pl)
PL (1) PL2346823T3 (pl)
PT (1) PT2346823E (pl)
WO (1) WO2010028232A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201500027TA (en) 2006-04-05 2015-02-27 Opko Health Inc Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor
MX2008012936A (es) 2006-04-05 2008-10-15 Schering Corp Formulaciones farmaceuticas: sales de 8-[{1-(3,5-bis-(trifluoromet il)fenil)-etoxi} metil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona y metodos de tratamiento usando las mismas.
AR066191A1 (es) 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
PL2346823T3 (pl) 2008-09-05 2016-01-29 Opko Health Inc Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu
AU2010282483B2 (en) 2009-08-14 2014-09-04 Opko Health, Inc. Intravenous formulations of neurokinin-1 antagonists
CN105017251B (zh) * 2015-06-30 2018-06-29 齐鲁制药有限公司 一种nk-1受体拮抗剂的制备方法及其中间体
CA2991898A1 (en) * 2015-07-15 2017-01-19 Opko Health, Inc. Heteroaryl carbonitriles for the treatment of disease
CN106866669A (zh) * 2017-04-19 2017-06-20 成都百特万合医药科技有限公司 一种合成罗拉吡坦中间体的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188472T1 (de) 1992-10-28 2000-01-15 Merck Sharp & Dohme 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
US5661162A (en) 1992-12-14 1997-08-26 Merck Sharp & Dohme Limited 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists
AU685212B2 (en) 1994-01-13 1998-01-15 Merck Sharp & Dohme Limited Gem-disubstituted azacyclic tachykinin antagonists
GB9626746D0 (en) 1996-12-23 1997-02-12 Knoll Ag Process
AU735760B2 (en) 1997-04-24 2001-07-12 Merck Sharp & Dohme Limited Use of a NK-1 receptor antagonist and an SSRI for treating obesity
DE19815275B4 (de) 1998-04-06 2009-06-25 Evonik Degussa Gmbh Alkylidenkomplexe des Rutheniums mit N-heterozyklischen Carbenliganden und deren Verwendung als hochaktive, selektive Katalysatoren für die Olefin-Metathese
US6215019B1 (en) 1998-09-01 2001-04-10 Tilliechem, Inc. Synthesis of 5-decenyl acetate and other pheromone components
WO2000071554A2 (en) 1999-05-24 2000-11-30 California Institute Of Technology Imidazolidine-based metal carbene metathesis catalysts
JP2003522739A (ja) 1999-12-17 2003-07-29 シェーリング コーポレイション 選択的ニューロキニンアンタゴニスト
GB0004699D0 (en) * 2000-02-28 2000-04-19 Merck Sharp & Dohme Chemical synthesis
JP3943015B2 (ja) 2000-08-10 2007-07-11 トラスティーズ オブ ボストン カレッジ リサイクル可能メタセシス触媒
JP4459621B2 (ja) * 2001-11-13 2010-04-28 シェーリング コーポレイション Ｎｋ１アンタゴニスト
GB0129525D0 (en) 2001-12-10 2002-01-30 Floor Image Internat Ltd Improvements to floor posters
PE20030762A1 (es) * 2001-12-18 2003-09-05 Schering Corp Compuestos heterociclicos como antagonistas nk1
PL199412B1 (pl) 2002-10-15 2008-09-30 Boehringer Ingelheim Int Nowe kompleksy rutenu jako (pre)katalizatory reakcji metatezy, pochodne 2-alkoksy-5-nitrostyrenu jako związki pośrednie i sposób ich wytwarzania
EP1747221B1 (en) * 2004-04-07 2009-07-01 Schering Corporation Fused ring nk1 antagonists
EP2522664B1 (en) 2004-07-01 2017-04-12 OPKO Health, Inc. Piperidine derivatives as NK1 antagonists
JP4444745B2 (ja) 2004-07-08 2010-03-31 キヤノン株式会社 偏光分離素子および画像投射装置
US7354922B2 (en) * 2004-12-14 2008-04-08 Schering Corporation Bridged ring NK1 antagonists
TW200630380A (en) 2005-02-18 2006-09-01 Nat Univ Chung Hsing N-acylamino acid racemase of Deinococcus radiodurans and producing method thereof, and L-amino acid production method therefrom
EP1905777B2 (en) 2005-07-04 2018-06-27 Zannan Scitech Co., Ltd. Ruthenium complex ligand, ruthenium complex, carried ruthenium complex catalyst and the preparing methods and the use thereof
SG10201500027TA (en) 2006-04-05 2015-02-27 Opko Health Inc Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor
MX2008012936A (es) 2006-04-05 2008-10-15 Schering Corp Formulaciones farmaceuticas: sales de 8-[{1-(3,5-bis-(trifluoromet il)fenil)-etoxi} metil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona y metodos de tratamiento usando las mismas.
TW200806666A (en) * 2006-04-05 2008-02-01 Schering Corp Salts of 8-[(1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
AR066191A1 (es) * 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
AR065802A1 (es) 2007-03-22 2009-07-01 Schering Corp Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
PL2346823T3 (pl) 2008-09-05 2016-01-29 Opko Health Inc Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu
AU2010282483B2 (en) 2009-08-14 2014-09-04 Opko Health, Inc. Intravenous formulations of neurokinin-1 antagonists

Also Published As

Publication number Publication date
AU2009289598A1 (en) 2010-03-11
AU2009289598B2 (en) 2014-09-11
CN104496988A (zh) 2015-04-08
CN102203062A (zh) 2011-09-28
ES2552322T3 (es) 2015-11-27
HUE026148T2 (en) 2016-05-30
US9822116B2 (en) 2017-11-21
PT2346823E (pt) 2015-11-26
HK1158623A1 (en) 2012-07-20
JP2012502053A (ja) 2012-01-26
EP2346823B1 (en) 2015-08-19
CA2736195A1 (en) 2010-03-11
US20140031549A1 (en) 2014-01-30
CA2736195C (en) 2017-05-16
MX2011002475A (es) 2011-08-03
EP3034493A1 (en) 2016-06-22
US9249144B2 (en) 2016-02-02
EP2346823A1 (en) 2011-07-27
KR20110067117A (ko) 2011-06-21
US20160145256A1 (en) 2016-05-26
CN104496988B (zh) 2017-04-12
JP2015143265A (ja) 2015-08-06
JP5736313B2 (ja) 2015-06-17
KR101719004B1 (ko) 2017-03-22
WO2010028232A1 (en) 2010-03-11
CN102203062B (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
PL2346823T3 (pl) Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu
HUS1700037I1 (hu) A 8-[{1-(3,5-bisz-(trifluor-metil)-fenil)-etoxi}-metil]-8-fenil-1,7-diazaspiro[4.5]dekan-2-on hidroklorid sója, és eljárás elõállítására
HK1202856A1 (en) 5-substituted isoindoline compounds 5-
ZA201103683B (en) Herbicidal compositions containing benzoylpyrazole compounds
AU2008229327A8 (en) Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as beta-secretase inhibitors
AP2010005364A0 (en) Novel heterocyclic compounds.
IL211744A0 (en) New chemical compounds
SI2384326T1 (sl) Pirolo(2,3-d)pirimidinske spojine
ZA201005097B (en) Herbicidal compounds
GB0800856D0 (en) Herbicidal compounds
GB0805318D0 (en) Herbicidal compounds
PL2767366T3 (pl) Wkład paliwowy
EP2106697A4 (en) HERBICIDAL COMPOSITIONS CONTAINING BENZOYLPYRAZOLE COMPOUNDS
EP2344337A4 (en) FLUID EJECTION CARTRIDGE
HK1141296A1 (en) Bridged six-membered ring compounds
EP2279576A4 (en) ERROR RATE MANAGEMENT
ZA201102944B (en) Insulting cartridge
SI2266990T1 (sl) Spojina 3-fenilpirazolo(5,1-b)tiazola
IL205181A0 (en) Compounds for inhibiting ksp kinesin activity
IL211292A0 (en) Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates
EP2244262A4 (en) DISC CARTRIDGE
IL213328A (en) Restoration of 2,2'-cyclopropylidene-bite @@ oxazolines I
PL2280961T3 (pl) Związki 1,5-difenylo-pirolidyn-2-onu jako ligandy CB-1
GB0715206D0 (en) Catalyst compounds
GB0817604D0 (en) Low molecular weight, non-polar compound depleted media